The FDA issued a safety alert regarding the design of endoscopic retrograde cholangiopancreatography duodenoscopes, and how it may impede effective cleaning of the reusable device.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
